Pharmaceutical firms' use of secondary patents to extend periods of exclusivity generates concerns among policymakers worldwide. In response, some developing countries have introduced measures to curb the grant of these patents. While these measures have received considerable attention, there is...

The upward-ratcheting of patent protection through trade agreements has generated significant concerns about potential effects on prices of drugs and access to medicines in developing countries. The Trans-Pacific Partnership (TPP) included even more extensive pharmaceutical patent provisions...

Books reviewed: Sonja Boehmer-Christiansen and Aynsley Kellow - International Environmental Policy: Interests and the Failure of the Kyoto Process Rolf Jungnickel (ed.) - Foreign-Owned Firms: Are They Different? Thomas Cottier and Petros C. Mavroidis (eds.) - Intellectual Property: Trade,...